 PARIS and CAMBRIDGE, Mass., April 26, 2021 GLOBE NEWSWIRE -- Biophytis SA Euronext Growth Paris: ALBPS, a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today provides updates and perspectives on its Sarconeos BIO101 programs ahead of its upcoming General Assembly on April 26, 2021. 